RANEXA RANOLAZINE 375MG TABLETS 60S

Ranolazine Celix is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists)

Posology and method of administration

Posology

Ranolazine is available as 375 mg, 500 mg, and 750 mg prolonged-release tablets.

Adults:

The recommended initial dose of Ranolazine Celix is 375 mg twice daily. After 2– 4 weeks, the dose should be titrated to 500 mg twice daily and, according to the patient’s response, further titrated to a recommended maximum dose of 750 mg twice daily (see section 5.1).

If a patient experiences treatment-related adverse events (e.g. dizziness, nausea, or vomiting), down-titration of Ranolazine Celix to 500 mg or 375 mg twice daily may be required. If symptoms do not resolve after dose reduction, treatment should be discontinued.